1300 related articles for article (PubMed ID: 12709465)
101. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.
Wilhelmsen L; Berglund G; Elmfeldt D; Fitzsimons T; Holzgreve H; Hosie J; Hörnkvist PE; Pennert K; Tuomilehto J; Wedel H
J Hypertens; 1987 Oct; 5(5):561-72. PubMed ID: 2892881
[TBL] [Abstract][Full Text] [Related]
102. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
[TBL] [Abstract][Full Text] [Related]
103. First-line drugs for hypertension.
Wright JM; Musini VM
Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
[TBL] [Abstract][Full Text] [Related]
104. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
[TBL] [Abstract][Full Text] [Related]
105. Prognostic significance of left ventricular mass change during treatment of hypertension.
Devereux RB; Wachtell K; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris K; Aurup P; Dahlöf B
JAMA; 2004 Nov; 292(19):2350-6. PubMed ID: 15547162
[TBL] [Abstract][Full Text] [Related]
106. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
Ambrosius WT; Sink KM; Foy CG; Berlowitz DR; Cheung AK; Cushman WC; Fine LJ; Goff DC; Johnson KC; Killeen AA; Lewis CE; Oparil S; Reboussin DM; Rocco MV; Snyder JK; Williamson JD; Wright JT; Whelton PK;
Clin Trials; 2014 Oct; 11(5):532-46. PubMed ID: 24902920
[TBL] [Abstract][Full Text] [Related]
107. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.
; Yusuf S; Pais P; Afzal R; Xavier D; Teo K; Eikelboom J; Sigamani A; Mohan V; Gupta R; Thomas N
Lancet; 2009 Apr; 373(9672):1341-51. PubMed ID: 19339045
[TBL] [Abstract][Full Text] [Related]
108. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
[TBL] [Abstract][Full Text] [Related]
109. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
110. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
[TBL] [Abstract][Full Text] [Related]
111. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ
JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047
[TBL] [Abstract][Full Text] [Related]
112. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
Bakris GL; Mangrum A; Copley JB; Vicknair N; Sadler R
Hypertension; 1997 Mar; 29(3):744-50. PubMed ID: 9052890
[TBL] [Abstract][Full Text] [Related]
113. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Schrader J; Lüders S; Kulschewski A; Hammersen F; Plate K; Berger J; Zidek W; Dominiak P; Diener HC;
Stroke; 2005 Jun; 36(6):1218-26. PubMed ID: 15879332
[TBL] [Abstract][Full Text] [Related]
114. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
[TBL] [Abstract][Full Text] [Related]
115. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
[No Abstract] [Full Text] [Related]
116. A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
Chrysant SG; Stimpel M
J Clin Pharmacol; 1996 Aug; 36(8):701-6. PubMed ID: 8877673
[TBL] [Abstract][Full Text] [Related]
117. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
Benetos A; Consoli S; Safavian A; Dubanchet A; Safar M
Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
[TBL] [Abstract][Full Text] [Related]
118. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
119. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
Perez MI; Musini VM; Wright JM
Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
[TBL] [Abstract][Full Text] [Related]
120. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
